Patients with S100A8/A9 values in the highest quartile had 2.0-fold increased odds of developing a recurrent cardiovascular event compared with those in the lowest quartile after adjusting for high-sensitivity C-reactive protein, hypertension, diabetes, previous cardiovascular disease, and heart failure (Morrow et al., 2008). This evidence concerns the gene S100A8 and hypertensive disorder.